These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 24457046)

  • 1. Inducible and coupled expression of the polyomavirus middle T antigen and Cre recombinase in transgenic mice: an in vivo model for synthetic viability in mammary tumour progression.
    Rao T; Ranger JJ; Smith HW; Lam SH; Chodosh L; Muller WJ
    Breast Cancer Res; 2014 Jan; 16(1):R11. PubMed ID: 24457046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement for both Shc and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis.
    Webster MA; Hutchinson JN; Rauh MJ; Muthuswamy SK; Anton M; Tortorice CG; Cardiff RD; Graham FL; Hassell JA; Muller WJ
    Mol Cell Biol; 1998 Apr; 18(4):2344-59. PubMed ID: 9528804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic Polyoma middle-T mice model premalignant mammary disease.
    Maglione JE; Moghanaki D; Young LJ; Manner CK; Ellies LG; Joseph SO; Nicholson B; Cardiff RD; MacLeod CL
    Cancer Res; 2001 Nov; 61(22):8298-305. PubMed ID: 11719463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PyV-mT-induced parotid gland hyperplasia as detected by altered lectin reactivity is not modulated by inducible nitric oxide deficiency.
    Ellies LG
    Arch Oral Biol; 2003 Jun; 48(6):415-22. PubMed ID: 12749913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: single origin, divergent evolution, and multiple outcomes.
    Maglione JE; McGoldrick ET; Young LJ; Namba R; Gregg JP; Liu L; Moghanaki D; Ellies LG; Borowsky AD; Cardiff RD; MacLeod CL
    Mol Cancer Ther; 2004 Aug; 3(8):941-53. PubMed ID: 15299077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muc1 affects c-Src signaling in PyV MT-induced mammary tumorigenesis.
    Al Masri A; Gendler SJ
    Oncogene; 2005 Sep; 24(38):5799-808. PubMed ID: 15897873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer.
    Denzel MS; Hebbard LW; Shostak G; Shapiro L; Cardiff RD; Ranscht B
    Clin Cancer Res; 2009 May; 15(10):3256-64. PubMed ID: 19447866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice.
    Guy CT; Muthuswamy SK; Cardiff RD; Soriano P; Muller WJ
    Genes Dev; 1994 Jan; 8(1):23-32. PubMed ID: 7507074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo.
    Lahlou H; Sanguin-Gendreau V; Frame MC; Muller WJ
    Breast Cancer Res; 2012 Feb; 14(1):R36. PubMed ID: 22373082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual recombinase action in the normal and neoplastic mammary gland epithelium.
    Rädler PD; Vistisen K; Triplett AA; Dennaoui R; Li Y; Shrestha H; Ferraiuolo RM; Thangasamy A; Saur D; Wagner KU
    Sci Rep; 2021 Oct; 11(1):20775. PubMed ID: 34675248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The simultaneous induction of tumorigenesis and Cre-loxP recombination in mice.
    Sakahara M; Ohkawara H; Nakao K; Yokozaki H; Aiba A
    Kobe J Med Sci; 2009 Mar; 54(6):E279-89. PubMed ID: 19628969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
    Brantley-Sieders DM; Zhuang G; Hicks D; Fang WB; Hwang Y; Cates JM; Coffman K; Jackson D; Bruckheimer E; Muraoka-Cook RS; Chen J
    J Clin Invest; 2008 Jan; 118(1):64-78. PubMed ID: 18079969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology.
    Gunther EJ; Belka GK; Wertheim GB; Wang J; Hartman JL; Boxer RB; Chodosh LA
    FASEB J; 2002 Mar; 16(3):283-92. PubMed ID: 11874978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalized tetracycline induced Cre recombinase expression through the ROSA26 locus of recombinant mice.
    Bäckman CM; Zhang Y; Malik N; Shan L; Hoffer BJ; Westphal H; Tomac AC
    J Neurosci Methods; 2009 Jan; 176(1):16-23. PubMed ID: 18801387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of
    Li YS; Meng RR; Chen X; Shang CL; Li HB; Zhang TJ; Long HY; Li HQ; Wang YJ; Wang FC
    G3 (Bethesda); 2019 Feb; 9(2):591-599. PubMed ID: 30591434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice.
    Yamazaki M; Akahane T; Buck T; Yoshiji H; Gomez DE; Schoeffner DJ; Okajima E; Harris SR; Bunce OR; Thorgeirsson SS; Thorgeirsson UP
    Carcinogenesis; 2004 Sep; 25(9):1735-46. PubMed ID: 15166086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mouse transgenic approach to induce β-catenin signaling in a temporally controlled manner.
    Mukherjee A; Soyal SM; Li J; Ying Y; Szwarc MM; He B; Kommagani R; Hodgson MC; Hiremath M; Cowin P; Lydon JP
    Transgenic Res; 2011 Aug; 20(4):827-40. PubMed ID: 21120693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
    Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL
    Cancer Res; 2005 Mar; 65(6):2296-302. PubMed ID: 15781643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic expression of polyomavirus middle T antigen in the mouse prostate gives rise to carcinoma.
    Lee SH; Jia S; Zhu Y; Utermark T; Signoretti S; Loda M; Schaffhausen B; Roberts TM
    J Virol; 2011 Jun; 85(11):5581-92. PubMed ID: 21411524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducible cardiomyocyte-specific gene disruption directed by the rat Tnnt2 promoter in the mouse.
    Wu B; Zhou B; Wang Y; Cheng HL; Hang CT; Pu WT; Chang CP; Zhou B
    Genesis; 2010 Jan; 48(1):63-72. PubMed ID: 20014345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.